Empiriko

Empiriko is a biotech company specializing in targeted radioligand therapies and antibody drug conjugates for cancer treatment, alongside next-generation point-of-care diagnostics. The company has developed an integrated technology platform that combines advances in medicinal chemistry, immunology, and engineering to enhance personalized precision... medicine. Their innovative drug delivery system aims to provide targeted therapies with minimal side effects, while their personalized metabolic fingerprint device enables real-time monitoring of disease and drug responses for at-risk patients. Empiriko's focus is on improving clinical outcomes for cancer and cardiovascular disease patients through cost-effective and customized treatment solutions.Read More